hodgkin lymphoma

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Survivors of Transplant, CREST Study

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bioelectric Impedance Analysis
  • +7 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 7, 2022

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

Completed
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • AB-205
  • Duarte, California
  • +8 more
Mar 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)

Completed
  • Hodgkin Lymphoma
  • Duarte, California
  • +12 more
Nov 3, 2021

Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)

Completed
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Camidanlumab tesirine
  • Duarte, California
  • +11 more
Jul 12, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
  • +2 more
  • Duarte, California
  • +2 more
Nov 19, 2018